跳至主要内容
临床试验/KCT0008160
KCT0008160尚未招募未知

Effect of high-intensity Statin with ezetimibe COmbination theRapy versus high-intensity sTatin monotherapy after percutaneous coronary intervention with drug-eluting stents; the ESCORT trial

Yonsei University Health System, Severance Hospital0 个研究点目标入组 4,310 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
入组人数
4,310

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
19(Year) 至 85(Year)(—)
性别
All

入选标准

  • 1. Age 19-85 years
  • 2. Patients who underwent coronary revascularization with newer generation DES implantation

排除标准

  • 1. Allergy or hypersensitive to ezetimibe or statin
  • 2. Active liver disease or persistent unexplained serum AST/ALT elevation more than 2 times the upper limit of normal range
  • 3. History of any adverse drug reaction requiring discontinuation of statin
  • 4. Pregnant women, women with potential childbearing, or lactating women
  • 5. Life expectancy less than 3 years
  • 6. Inability to follow the patient over the period of 1 year after enrollment, as assessed by the investigator
  • 7. Inability to understand or read the informed content

研究者

相似试验